Effectiveness of Umonium³⁸ against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA).

ABSTRACT:

Aims

We investigated the antibacterial efficacy of Umonium³⁸ and Virkon^® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment.

Methods and results

Umonium³⁸ was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%, tested against the bacterial strains at various contact times (15 min to 24 h), and incubated for up to 14 days. A minimum concentration of 0.5% Umonium³⁸ with a contact time of 15 min effectively killed approximately 10⁸ CFU/ml of all four bacterial species. No growth was observed on agar plates from day 0 until day 14 for all six concentrations. The bacteria were also inactivated by a 30-minute treatment

SUBMITTER: Ruanchaiman S 

PROVIDER: S-EPMC10873964 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature